DexCom stock falls over 38% as revenue forecast declines
The company revised its annual revenue forecast to $4bn, down from its previous estimate of $4.2bn-$4.35bn.
![](https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/07/shutterstock_2312773451.jpg)
The company revised its annual revenue forecast to $4bn, down from its previous estimate of $4.2bn-$4.35bn.
Immunis’ secretome therapy is being evaluated in elderly patients with knee osteoarthritis.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Deepc adds $13m series A extension for AI radiology platform
Spectral AI adds three southern US sites to AI burn assessment study
Healthcare cybersecurity risk ‘higher than ever’ due to pandemic
How are wearable patches revolutionising women’s health?